Sources last read
What Foundayo costs, and who each price is for
Lilly publishes a $649 wholesale acquisition cost for every 30-tablet bottle of Foundayo. Its current self-pay program starts at $149 a month, and eligible commercial coverage can start at $25.
Source: Read from Eli Lilly and Company’s own program terms, 2026-09-06
What matters first
Reviewed 2026-09-06every price here is sourced
The manufacturer program prices on this page were read from the manufacturer’s own terms on 2026-09-06. Those terms say they can change at any time, without notice. The terms themselves state that they expire on 2026-12-31 — after that date, treat every figure on this page as history until it has been read again.
What does Foundayo cost if your plan covers it?
The $25 offer is for eligible adults whose commercial plan covers Foundayo. Lilly caps its payment at $100 for one month, $200 for two months, or $300 for three months. The yearly cap is $1,000 across no more than 10 fills, and the card expires on 2026-12-31. If the plan does not cover Foundayo, prices and savings caps vary by dose. Both offers require a prescription for a use covered by the FDA label.
| Your situation | What Foundayo costs | What the card pays | Fills a year |
|---|---|---|---|
| Commercial insurance that covers Foundayo | As little as $25 for a 1-month, 2-month or 3-month fill | The card pays up to $100, $200 or $300 by fill length, and up to $1,000 in a calendar year | 10 |
| Commercial insurance that does not cover Foundayo | $149 at 0.8 or 2.5 mg, $199 at 5.5 mg, and $299 at 9, 14.5 or 17.2 mg | The maximum monthly savings is $520, $470 or $370 depending on dose | 10 |
Read from Eli Lilly and Company — manufacturer program terms · retrieved 2026-09-06 · the card’s own terms say it expires 2026-12-31
What is the list price of Foundayo?
Lilly calls this the wholesale acquisition cost. It is the listed distribution price before discounts, rebates and other changes. It is not a promise of what a patient pays.
$649.00 — wholesale acquisition cost per bottle of 30 tablets, at every strength.
Read from Lilly USA, LLC — manufacturer price disclosure · retrieved 2026-09-06 · the publisher’s own wholesale-price disclosure
What does Foundayo cost without insurance?
Lilly’s self-pay terms publish six dose-specific prices for a 30-day supply. The starting 0.8 mg dose is $149; the 9 mg dose is $299. Two middle doses are temporarily reduced through the end of 2026.
At 14.5 mg and 17.2 mg, $299 is a purchase offer with a 45-day refill clock. If the next purchase happens later, Lilly says the regular price is $349.
The $649 figure is separate from the self-pay table. Lilly calls it the wholesale acquisition cost for 30 tablets. It is a distribution price before rebates and other changes, not an offer to a patient.
| Dose | A month costs | What is attached to it |
|---|---|---|
| 0.8 mg | $149 | Regular self-pay price |
| 2.5 mg | $149 | Temporarily reduced through 2026-12-31; regular price $199 |
| 5.5 mg | $199 | Temporarily reduced through 2026-12-31; regular price $299 |
| 9 mg | $299 | Regular self-pay price |
| 14.5 mg | $299 | Purchase offer requires the next refill within 45 days; regular price $349 |
| 17.2 mg | $299 | Purchase offer requires the next refill within 45 days; regular price $349 |
Read from Eli Lilly and Company — manufacturer program terms · retrieved 2026-09-06 · a month here means 30 days and 30 tablets
The catch on that price
This is Lilly’s separate Self-Pay Savings Card program. It permits up to 10 fills per calendar year and expires on 2026-12-31. The monthly savings cap is $520 at 0.8 and 2.5 mg, $470 at 5.5 mg, and $370 at 9, 14.5, or 17.2 mg. The first $299 purchase at 14.5 mg or 17.2 mg is automatic. Keeping that price requires the next purchase within 45 days of the previous delivery or receipt.
The program is for cash-paying patients and runs outside insurance. Lilly says you cannot seek or accept reimbursement from private insurance, a government program, or a healthcare reimbursement account. You also cannot apply those costs toward a deductible or true out-of-pocket requirement.
What if you are on Medicare?
Lilly lists Foundayo at $50 a month through the Medicare GLP-1 Bridge for eligible Part D patients with a prescription for weight management.
Lilly’s Foundayo page lists the Medicare GLP-1 Bridge at $50 per month for eligible Part D patients with a Foundayo prescription for weight management. It says this is not a guarantee of coverage and eligibility follows the program’s clinical criteria.
Read from Eli Lilly and Company — manufacturer program terms · retrieved 2026-09-06
3Price details
Can you use the card at all?
Eli Lilly and Company sets conditions beyond the exclusion above, and you attest to all of them when you enroll. Getting one wrong is what turns a $25 month into a full-price one.
- You are 18 or older and live in the United States or Puerto Rico.
- You have commercial drug insurance and a prescription for a use the FDA label covers.
- You are not enrolled in a state, federal or government-funded healthcare program.
We do not print a code, and there is none to print. The card is issued by Eli Lilly and Company to you, after you say you meet those terms. Nothing on this page is an offer, and we do not supply, arrange or guarantee any discount.
What makes Foundayo different on price
Foundayo cash prices change by dose. The 14.5 mg and 17.2 mg offers also have a refill deadline. The $299 offer stays in place only if the next purchase happens within 45 days. Lilly lists $349 as the regular price.
Foundayo is orforglipron from Eli Lilly and Company, approved under NDA 220934. Its price ladder tracks its dose ladder, which starts at 0.8 mg and stops at 17.2 mg. That is why a quote taken in your first month is a quote for a dose you are meant to leave.
Where to read next
Use the links below to continue with the pages available for this brand. Cost stays separate so each topic can be updated from its own source.
- The Foundayo dose schedule reads the ladder off the label, step by step.
- Foundayo side effects carries the label’s own trial table.
- The generic record for Foundayo is pending because orforglipron was not read in the current FDA approval-file snapshot. No generic or acquisition-cost comparison is published yet.
- What all of these cost, side by side puts this price next to every other one on the site.
2 program documents — every price on this page was read from one of them
- Foundayo coverage and savings — commercial card, self-pay prices and Medicare route · Eli Lilly and Company · manufacturer program terms · retrieved 2026-09-06
- Foundayo Connecticut prescriber disclosure — wholesale acquisition cost by strength · Lilly USA, LLC · manufacturer price disclosure · retrieved 2026-09-06